WEST LAFAYETTE, Ind., Aug. 4, 2011 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that the company will host a conference call on Thursday, August 11, 2011, at 4:30 PM Eastern Daylight Time to discuss its second quarter 2011 financial results and provide an operational update.
